Sun, Aug 18 9:02am

Compare RTRX

Retrophin Inc [RTRX]
$17.80 0.80 (4.71%)

RTRX Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 730 Million
RTRX Description

Retrophin Inc serves in the healthcare sector based in the United States. As a pharmaceutical products manufacturer, it develops drugs to treat serious and rare diseases. Its suite of drug candidates includes Chenodal, to combat gallstones; Cholbam, which is approved for the treatment of bile acid synthesis disorders and Thiola, which addresses kidney stone formation.

Visit Website

RTRX Earnings

EPS -0.92 P/E Ratio 0.00
Previous Earnings Tue, May 7, 2019
Latest Earnings Tue, Aug 6, 2019 (12 days ago) -5.67%

RTRX Dividend

Yield --
Ex-Date --
Pay Date --
History --

RTRX Charts

1 Year
Aug 7, 2019
Sep 4, 2018

Symbol Price Day % YTD %
RTRX $17.80 4.71% -21.48%

Symbol Surfing

How can we make Symbol Surfing better?

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy